SELLAS Life Sciences Group, Inc. SLS Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets?
- SELLAS Life Sciences Group, Inc. (SLS) reported operating lease right-of-use assets in other assets of $839K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets increased by 4.1% year-over-year, from $806K to $839K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s operating lease right-of-use assets in other assets has grown at a 1.5% compound annual growth rate (CAGR), from $896K to $963K.